1
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Management of Metastatic Lesions of Bone

Part 2, Chemotherapeutic Aspects

, M.D., , M.D. & , M.D.
Pages 576-581 | Published online: 18 Apr 2016

REFERENCES

  • Fort, W. A.: Cancer metastatic to bone. Radiology 24: 96–98 (January) 1935.
  • Abrams, H. L., Spiro, R. and Goldstein, N.: Metastases in carcinoma: Analysis of 1,000 autopsied cases. Cancer 3: 74–85 (January) 1950.
  • Paterson, R.: Treatment of Malignant Disease by Radiotherapy. Baltimore, The Williams & Wilkins Company, 1963.
  • Delclos, L. and Johnson, G. C.: Palliative irradiation in breast cancer. Radiology 83: 272–276 (August) 1964.
  • Storaasli, J. P., King, R. L., Krieger, H., Abbott, W. E. and Friedell, H. L.: Palliation of osseous metastases from breast carcinoma with radioactive phosphorus alone and in combination with adrenalectomy. Radiology 76: 422–429, 1961.
  • Maxfield, J. R., Jr., Maxfield, J. G. S. and Maxfield, W. S.: The use of radioactive phosphorus and testosterone in metastatic bone lesions from breast and prostate. Southern Med J 51: 320–328 (March) 1958.
  • American Medical Association Council on Drugs: Androgens and estrogens in the treatment of disseminated mammary carcinoma. Retrospective study of nine hundred forty-four patients. JAMA 172: 1271–1283 (March 19) 1960.
  • Treves, N.: Endocrine therapy in advanced mammary cancer. Am Pract & Digest Treat 5: 518–525 (July) 1954.
  • Kennedy, B. J.: Hormonal therapy in mammary carcinoma. In Pack, G. T. and Ariel, I. M. (Editors): Treatment of Cancer and Allied Diseases. Ed. 2. New York, Paul B. Hoeber, Inc., Medical Division of Harper & Brothers, 1960, vol. 4, chap. 9A, pp. 178–204.
  • Kaufman, J. and Escher, C.: Rebound regression in advanced mammary carcinoma. Surg Gynec Obstet 113: 635–640 (November) 1961.
  • Kennedy, B. J.: Fluoxymesterone therapy in advanced breast cancer. New Eng J Med 259: 673–675 (October 2) 1958.
  • Blackburn, C. M. and Childs, D. S., Jr.: Use of 2 alpha-methyl androstan-17 beta-ol, 3-one (2- methyl dihydrostestosterone) in the treatment of advanced cancer of the breast. Proc Mayo Clin 34: 113–126 (March 4) 1959.
  • Lemon, H. M.: Prednisone therapy of advanced mammary cancer. Cancer 12: 93–107 (January-February) 1959.
  • Gordan, G. S., Graham, W. P., III, Goldman, L., Papac, R., Sheline, G. E., Vaeth, J. and Witt, J.: Hormonal treatment of disseminated cancer of the female breast. Calif Med 98: 189–194 (April) 1963.
  • Gordon, D. L. and Segaloff, A.: Castration as palliative therapy for advanced breast cancer. The Second Biennial Louisiana Cancer Conference. St. Louis, The C. V. Mosby Company, 1958, p. 187.
  • Ansfield, F. J., Schroeder, J. M. and Curreri, A. R.: Five years' clinical experience with 5-fluorouracil. JAMA 181: 295–299 (July 28) 1962.
  • Ivy, H. K.: Treatment of breast cancer with 5-fluorouracil. Ann Intern Med 57: 598–605, 1962.
  • Foley, J. F. and Kennedy, B. J.: Effect of cyclophosphamide (NSC-26271) on far-advanced neoplasia. Cancer Chemother Rep 34: 55–58, 1964.
  • Bateman, J. C. and Carlton, H. N.: The role of chemotherapy in the treatment of breast cancer. Surgery 47: 895–907 (June) 1960.
  • Whitelaw, D. M. and Kim, H. S.: Vincristine in the treatment of neoplastic disease. Canad Med Ass J 90: 1385–1389 (June 20) 1964.
  • Forssberg, A.: Study of distribution of radioactive phosphorus in 3 cases of cancer. Acta Radiol 27: 88–92, 1946.
  • Treves, N.: The treatment of cancer, especially inoperable cancer, of the male breast by ablative surgery (orchiectomy, adrenalectomy, and hypophysectomy) and hormone therapy (estrogens and corticosteroids): An analysis of 42 patients. Cancer 12: 820–832 (July-August) 1959.
  • Nesbit, R. M. and Baum, W. C.: Endocrine control of prostatic carcinoma. Clinical and statistical survey of 1,818 cases. JAMA 143: 1317–1320 (August 12) 1950.
  • Brendler, H. and Prout, G., Jr.: A cooperative group study of prostatic cancer: Stilbestrol versus placebo in advanced progressive disease. Cancer Chemother Rep 16: 323–328 (February) 1962.
  • Kaplan, E., Fels, I. G., Kotlowski, B. R., Greco, J. and Walsh, W. S.: Therapy of carcinoma of the prostate metastatic to bone with P32-labeled condensed phosphate. J Nucl Med 1: 1–13, 1960.
  • Bloom, H. J. G. and Wallace, D. M.: Hormones and the kidney: Possible therapeutic role of testosterone in a patient with regression of metastases from renal adenocarcinoma. Brit Med J 5407: 476–480 (August 22) 1964.
  • Koop, C. E.: Current management of nephroblastoma and neuroblastoma. Amer J Surg 107: 497–501 (March) 1964.
  • Frazell, E. L. and Foote, F. W., JR.: The natural history of thyroid cancer. A review of 301 cases. J Clin Endocr 9: 1023–1030 (October) 1949.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.